July 27, 2026

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 14.97% Upside Potential

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, stands as a compelling investment opportunity in the diagnostics and research industry. With a robust market capitalization of..

Corcept Therapeutics (CORT) Stock Analysis: Unveiling a Potential 11.16% Upside in Biotech

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has been capturing investor attention with its promising pipeline of medications targeting severe endocrinologic and oncologic disorders. Headquartered..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth with a 52.60% Revenue Surge

Oscar Health, Inc. (NYSE: OSCR) is making waves in the healthcare sector with its impressive revenue growth, capturing the attention of savvy investors. With the company reporting a staggering 52.60%..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 16% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) represents a compelling opportunity within the diagnostics & research industry, particularly for those interested in the burgeoning field of precision oncology. With a current market..

Globus Medical, Inc. (GMED) Stock Analysis: 38.25% Potential Upside Beckons Investors in Healthcare Innovation

For investors eyeing the healthcare sector, Globus Medical, Inc. (NYSE: GMED) presents a compelling opportunity with a notable potential upside of 38.25%. Headquartered in Audubon, Pennsylvania, Globus Medical is a..

Bruker Corporation (BRKR) Stock Analysis: Navigating the Intriguing Valuation Landscape in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly in the medical devices industry, is capturing investor attention with its innovative approach to scientific instruments and diagnostics...

Repligen Corporation (RGEN)

⚠️ No article content returned.

..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Evaluating a Potential 35% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a key player in the biotechnology sector, is garnering attention with its promising portfolio focused on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical company based..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Biotech Giant with 41% Upside Potential

Sarepta Therapeutics, Inc. (SRPT), a leading player in the biotechnology sector, has been making waves in the healthcare industry, primarily through its cutting-edge RNA-targeted therapeutics and gene therapy platforms. Despite..

Quest Diagnostics (DGX) Stock Analysis: Deciphering Growth Potential Amid Strong Revenue Trajectory

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable entity in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $25.15 billion, this U.S.-based..

Investor Outlook: Bausch + Lomb Corporation (BLCO) Eyes 12% Upside Potential Amid Steady Growth

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors looking for exposure to the eye..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a 5.13% Potential Upside and Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), based in Dublin, Ireland, stands out in the biotechnology sector with a market cap of $15.93 billion. As a key player in the healthcare industry,..

ICON plc (ICLR) Stock Analysis: Investor Outlook on Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), headquartered in Dublin, Ireland, stands as a leading figure in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $12.79..

Biogen Inc. (BIIB) Stock Analysis: Navigating Biotech’s Promising Growth Potential

Biogen Inc. (BIIB) stands as a formidable player in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization of $29.85 billion, Biogen’s influence extends across..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating Growth Potential in the Oncology Market

Exelixis, Inc. (EXEL), a prominent player in the biotechnology sector, continues to capture investor interest with its dedicated focus on developing innovative cancer treatments. With a market capitalization of $13.92..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 105.56% Potential Upside in the Booming Biotech Sector

In the ever-evolving landscape of biotechnology, ADMA Biologics Inc (NASDAQ: ADMA) presents a compelling case for investors eyeing growth opportunities in the healthcare sector. With a market capitalization of $1.92..

HealthEquity, Inc. (HQY) Stock Analysis: A Strong Buy with 25% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the Health Information Services industry, stands out as a compelling investment opportunity. With a market capitalization of $7.93 billion, this healthcare technology..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Stable Yet Competitive Landscape

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a robust market cap of $8.42 billion, Bio-Rad is..

Masimo Corporation (MASI) Stock Analysis: Evaluating Growth Potential in Healthcare Tech

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, has carved a niche in the medical devices industry by focusing on innovative patient monitoring technologies. With a market..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Healthcare Innovation with an 11.51% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare diagnostics and research industry, offers a compelling investment case for those seeking exposure to healthcare innovation and analytics. Based..

Search

Funds

July 27, 2026

Search

Funds

July 27, 2026

FTSE 100

Funds